Abstract
Purpose of Review
This review provides an overview of the current literature surrounding the medical and surgical treatment of aortic graft infection with particular focus on the role of endovascular aortic grafts in the changing demographics and management of these infections.
Recent Findings
Definitive therapy for aortic graft infection continues to include parenteral antibiotics and surgical explantation and revascularization procedures, which are historically vast operations and sources of significant operative stress. Surgical management has evolved to include more options for infection resistant in situ conduits, attempts at partial explantations, and use of endovascular therapy to temporize the urgent sequelae of these infections, such as aortoenteric fistula.
Summary
Aortic graft infection continues to be a significant and morbid complication of graft placement even with the advent of endovascular therapy, and its treatment will only increase in difficulty as a more frail population has gained access to complex aortic repair. In the future, more flexible revascularization and partial explantation options are keys, along with long-term suppressive antibiotics where appropriate.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Ali A, Modrall G, Hocking J, Valentine RJ, Spencer J, Eidt JF, et al. Long-term results of the treatment of aortic graft infection by in situ replacement with popliteal vein grafts. J Vasc Surg. 2009;50(1):30–9.
Harlander-Locke M, Harmon LK, Lawrence PF, Oderich GS, McCready RA, Morasch MD, et al. The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg. 2014;59(3):669–74.
Oderich G, Bower TC, Hofer J, Kalra M, Duncan AA, Wilson JW, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg. 2011;53(1):99–106.
Kilic A, Arnaoutakis DJ, Reifsnyder T, Black JH III, Abularrage CJ, Perler BA, et al. Management of infected vascular grafts. Vasc Med. 2016;21(1):53–60.
Dua A, Upchurch GR, Lee JT, Eidt J, Desai SS. Predicted shortfall in open aneurysm experience for vascular surgery trainees. J Vasc Surg. 2014;60(4):945–9.
Kilic A, Shah AS, Black JH III, Whitman GJR, Yuh DD, Cameron DE, et al. Trends in repair of intact and ruptured descending thoracic aortic aneurysms in the United States: a population-based analysis. J Thorac Cardiovasc Surg. 2014;147(6):1855–60.
• Berger P, Vaartjes I, Moll FL, De Borst GJ, Bankensteijn JD, Bots ML. Cumulative incidence of graft infection after primary prosthetic aortic reconstruction in the endovascular era. Eur J Vasc Endovasc Surg. 2015;49(5):581–5. A comprehensive overview of trends in incidence of graft infection since the advent of endovascular therapy.
Strosberg D, Oriowo BA, Davies MG, El Sayed HF. The role of endovascular in situ revascularization in the treatment of arterial and graft infections. Ann Vasc Surg. 2017;42:e15–299.
Fatima J, Duncan AA, de Grandis E, Oderich GS, Kalra M, Gloviczki P, et al. Treatment strategies and outcomes in patients with infected aortic endografts. J Vasc Surg. 2013;58(2):371–9.
Lyons O, Patel AS, Saha P, Clough RE, Price N, Taylor PR. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg. 2013;46(3):306–13.
• Smeds M, Duncan AA, Harlander-Locke MP, Lawrence PF, Lyden S, Fatima J, et al. Treatment and outcomes of aortic endograft infection. J Vasc Surg. 2016;63(2):332–40. Outcomes of the treatment of graft infection particularly germane to aortic endografts, highlighting new challenges of these infections and comparing outcomes to the previous experience with aortic graft infection.
Laser A, Baker N, Rectenwald J, Eliason JL, Criado-Pallares E, Upchurch GR Jr. Graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2011;54(1):58–63.
Davila V, Stone W, Duncan AA, Wood E, Jordan WD Jr, Zea N, et al. A multicenter experience with the surgical treatment of infected abdominal aortic endografts. J Vasc Surg. 2015;62(4):877–83.
Murphy E, Szeto WY, Herdrich BJ, Jackson BM, WAng GJ, Bavaria JE, et al. The management of endograft infections following endovascular thoracic and abdominal aneurysm repair. J Vasc Surg. 2013;58(5):1179–85.
•• Hodgkiss-Harlow K, Bandyk DF. Antibiotic therapy of aortic graft infection: treatment and prevention recommendations. Semin Vasc Surg. 2011;24(4):191–8. An in-depth review of pathogens and antibiotic treatment and delivery strategies in all types of aortic graft infection.
Lyons O, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of aortic graft infection: a case definition by the management of aortic grafic infection collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52(6):758–63.
Liberatore M, Iurilli AP, Ponzo F, Prosperi D, Santini C, Baiocchi P, et al. Clinical usefulness of technetium-99m-HMPAO-labeled leukocyte scan in prosthetic vascular graft infection. J Nucl Med. 1998;39(5):875–9.
Sah B, Husmann L, Mayer D, Scherrer A, Rancic Z, Puippe G, et al., the Vasgra Cohort. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infection. Eur J Vasc Endovasc Surg. 2015;49(4):455–64.
Shahani L. Vascular graft infections and role of PET/CT in patients with persistent bacteraemia. BMJ Case Reports. 2015; https://doi.org/10.1136/bcr-2014-207678.
Semba C, Sakai T, Slonim SM, Razavi MK, Kee ST, Jorgensen MJ, et al. Mycotic aortic aneurysms of the thoracic aorta repair with use of endovascular stent-grafts. Journal of Vascular Interventional Radiology. 1998;9(1):33–40.
Kan C, Lee HL, Yang YJ. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007;46(5):906–12.
Razavi M, Razavi MD. Stent-graft treatment of mycotic aneurysms: a review of the current literature. Journal of Vascular Interventional Radiology. 2008;19(Suppl 6):S51–6.
Haidar G, Hicks TD, Strosberg DS, El-Sayed HF, Davies MG. “In situ” endografting in the treatment of arterial and graft infection. J Vasc Surg. 2017;65(6):1824–9.
Reilly L, Stoney RJ, Goldstone J, Ehrenfeld WK. Improved management of aortic graft infection: the influence of operation sequence and staging. J Vasc Surg. 1987;5(3):421–31.
Berger P, Moll FL. Aortic graft infections: is there still a role for axillobifemoral reconstruction? Semin Vasc Surg. 2011;24(4):205–10.
Aizawa K, Ohki S, Konishi H, Misawa Y. Extraanatomical ascending-abdominal aorta bypass with stump closure for aortic graft infection. Interact Cardiovasc Thorac Surg. 2008;7(4):646–7.
Riesenman P, Farber MA. Management of a thoracic endograft infeciton through an ascending to descending extra-anatomic aortic bypass and endograft explantation. J Vasc Surg. 2010;51(1):207–9.
Clagett G, Bowers BL, Lopez-Viego MA, Rossi MB, Valentine RJ, Myers SI, et al. Creation of a neo-aortoiliac system from lower extremity deep and superficial veins. Ann Surg. 1993;218(3):239–48.
Beck A, Murpy EH, Hocking JA, Timaran CH, Arko FR, Clagett GP. Aortic reconstruction with femoral-popliteal vein: graft stenosis incidence, risk and reintervention. J Vasc Surg. 2007;47(1):36–43.
Ali A, McLeod N, Kalapatapu VR, Moursi MM, Eidt JF. Staging the neoaortoiliac system: feasibility and short-term outcomes. J Vasc Surg. 2008;48(5):1125–30.
Simmons C, Ali AT, Foteh K, Abate MR, Smeds MR, Spencer HJ, et al. Unilateral inline replacement of infected aortofemoral graft limb with femoral vein. J Vasc Surg. 2017;65(4):1121–9.
Noel A, Gloviczki P, Cherry KJ Jr, Safi H, Goldstone J, Morasch MD, et al. Abdominal qaortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg. 2002;35(5):847–52.
Heo S, Kim YW, Woo SY, Park YJ, Kim DK, Chung DR. Recent results of in situ abdominal aortic reonstruction with cryopreserved arterial allograft. Eur J Vasc Endovasc Surg. 2017;53(2):158–67.
Della Schiava N, Mathevet JL, Boudjelit T, Arsicot M, Feugier P, Lermusiaux P, et al. Cryopreserved arterial allografts and ABO and rhesus compatibility. Ann Vasc Surg. 2016;33:173–80.
Solanes N, Rigol M, Khabiri E, Castella M, Ramirez J, Roque M, et al. Effects of cryopreservation on the immunogenicity of porcine arterial allografts in early stages of transplant vasculopathy. Cryobiology. 2005;51(2):130–41.
Zehr B, Niblick CJ, Downey H, Ladowski JS. Limb salvage with CryoVein cadaver saphenous vein allografts used for peripheral arterial bypass: role of blood compatibility. Ann Vasc Surg. 2011;25(2):177–81.
Lew W, Moore W. Antibiotic-impregnated grafts for aortic reconstruction. Semin Vasc Surg. 2011;24(4):211–9.
Lutz B, Reeps C, Biro G, Knappich C, Zimmermann A, Eckstein HH. Bovine pericardium as new technical option for in situ reconstruction of aortic graft infection. Ann Vasc Surg. 2017;41:118–26.
van Zitteren M, van der Steenhoven TJ, Burger DHC, van Berge Henegouwen DP, Heyligers JMM, Vriens PWHE. Spiral vein reconstruciton of the infected abdominal aorta using the greater saphenous vein: preliminary results of the Tilburg experience. Eur J Vasc Endovasc Surg. 2011;41(5):637–46.
Berard X, Stecken L, Pinaquy J-B, Cazanave C, Puges M, Pereyre S, et al. Comparison of the antimicrobial properties of silver impregnated vascular grafts with and without triclosan. Eur J Vasc Endovasc Surg. 2016;51(2):285–93.
Aboshady I, Raad I, Vela D, Hassan M, Aboshady Y, Safi HJ, et al. Prevention of perioperative vascular prosthetic infection with a novel triple antimicrobial-bonded arterial graft. J Vasc Surg. 2015;64(6):1805–14.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Drs Sorber, Osgood, Abularrage, Black and Lum declare that they have no conflicts of interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the authors.
Additional information
This article is part of the Topical Collection on Intra-abdominal Infections, Hepatitis, and Gastroenteritis
Rights and permissions
About this article
Cite this article
Sorber, R., Osgood, M.J., Abularrage, C.J. et al. Treatment of Aortic Graft Infection in the Endovascular Era. Curr Infect Dis Rep 19, 40 (2017). https://doi.org/10.1007/s11908-017-0598-1
Published:
DOI: https://doi.org/10.1007/s11908-017-0598-1